相关实验视频
Updated: Jun 10, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
一个基于CT的新型骨折风险预测模型,用于COPD患者
Heqi Yang1, Yang Li2, Hui Yang1
1The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong, China (H.Y., H.Y., Z.S., Q.Y., C.J., M.S., J.Q.).
一种新的基于计算机断层扫描 (CT) 的骨折风险评估模型 (FRCT) 准确地预测慢性阻塞性肺病 (COPD) 患者的骨质疏松性骨折. 该工具改进了针对个性化风险管理的现有方法.
科学领域:
- 医疗成像医学成像
- 肺部病理学 肺部病理学
- 骨健康 骨健康 骨健康
背景情况:
- 慢性阻塞性肺病 (COPD) 与骨质疏松性骨折的风险增加有关.
- 现有的骨折风险评估工具可能无法充分捕捉COPD患者的特定风险.
研究的目的:
- 为COPD患者开发和验证一种基于计算机断层扫描 (CT) 的新型骨折风险评估模型 (FRCT).
- 为了提高骨折风险预测在这个弱势群体的准确性.
主要方法:
- 对284名COPD患者的回顾性分析.
- 利用了人口,临床,肺功能和基于CT的骨量化数据.
- 雇佣Boruta的特征选择用于模型开发,创建一个名ogram.
主要成果:
- 37.32%的患者在随访后经历了脆弱性骨折.
- 与FRAX相比,FRCT模型,包括年龄,骨度指标,HDL和先前的骨折,显示出更高的预测准确度 (C指数0.773-0.797).
- 该模型显示出出色的校准和显著的临床实用性.
结论:
- 该FRCT模型提供准确的,个性化的骨折风险预测在COPD患者使用机会性CT扫描.
- 这种新的工具超越了当前的评估方法,对于管理COPD骨质疏松性骨折风险非常有价值.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids